These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 16615554)

  • 1. [Hypersensitivity to mosquito bites and hydroa vacciniforme].
    Iwatsuki K; Yamamoto T; Tsuji K
    Nihon Rinsho; 2006 Mar; 64 Suppl 3():657-61. PubMed ID: 16615554
    [No Abstract]   [Full Text] [Related]  

  • 2. Survival rates and prognostic factors of Epstein-Barr virus-associated hydroa vacciniforme and hypersensitivity to mosquito bites.
    Miyake T; Yamamoto T; Hirai Y; Otsuka M; Hamada T; Tsuji K; Morizane S; Suzuki D; Aoyama Y; Iwatsuki K
    Br J Dermatol; 2015 Jan; 172(1):56-63. PubMed ID: 25234411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites.
    Miyake T; Iwatsuki K; Hirai Y; Yamamoto T; Hamada T; Fujii K; Imamura H; Morizane S
    J Med Virol; 2020 Dec; 92(12):3689-3696. PubMed ID: 32255500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Epstein-Barr virus-infected natural killer lymphocytes in a patient with hypersensitivity to mosquito bites.
    Yamamoto T; Fujii K; Tsuji K; Akazai A; Oda M; Imai S; Iwatsuki K
    J Am Acad Dermatol; 2005 Nov; 53(5):912-4. PubMed ID: 16243163
    [No Abstract]   [Full Text] [Related]  

  • 5. Epstein-Barr virus reactivation is induced, but abortive, in cutaneous lesions of systemic hydroa vacciniforme and hypersensitivity to mosquito bites.
    Yamamoto T; Hirai Y; Miyake T; Hamada T; Yamasaki O; Morizane S; Fujimoto W; Iwatsuki K
    J Dermatol Sci; 2016 Jun; 82(3):153-9. PubMed ID: 27039668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydroa vacciniforme is associated with increased numbers of Epstein-Barr virus-infected γδT cells.
    Hirai Y; Yamamoto T; Kimura H; Ito Y; Tsuji K; Miyake T; Morizane S; Suzuki D; Fujii K; Iwatsuki K
    J Invest Dermatol; 2012 May; 132(5):1401-8. PubMed ID: 22297643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular lesion in a patient of chronic active Epstein-Barr virus infection with hypersensitivity to mosquito bites: vasculitis induced by mosquito bite with the infiltration of nonneoplastic Epstein-Barr virus-positive cells and subsequent development of natural killer/T-cell lymphoma with angiodestruction.
    Kanno H; Onodera H; Endo M; Maeda F; Chida S; Akasaka T; Sawai T
    Hum Pathol; 2005 Feb; 36(2):212-8. PubMed ID: 15754300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T-lymphocyte-induced Epstein-Barr virus reactivation in a patient with severe hypersensitivity to mosquito bites and Epstein-Barr virus-infected NK cell lymphocytosis.
    Asada H; Miyagawa S; Sumikawa Y; Yamaguchi Y; Itami S; Suguri S; Harada M; Tokura Y; Ishihara S; Ohshima S; Yoshikawa K
    Arch Dermatol; 2003 Dec; 139(12):1601-7. PubMed ID: 14676078
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypersensitivity to mosquito bites is not an allergic disease, but an Epstein-Barr virus-associated lymphoproliferative disease.
    Ishihara S; Yabuta R; Tokura Y; Ohshima K; Tagawa S
    Int J Hematol; 2000 Aug; 72(2):223-8. PubMed ID: 11039673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypersensitivity to mosquito bites with natural-killer cell lymphocytosis: the possible implication of Epstein-Barr virus reactivation.
    Satoh M; Oyama N; Akiba H; Ohtsuka M; Iwatsuki K; Kaneko F
    Eur J Dermatol; 2002; 12(4):381-4. PubMed ID: 12095889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypersensitivity to mosquito bites: a unique pathogenic mechanism linking Epstein-Barr virus infection, allergy and oncogenesis.
    Asada H
    J Dermatol Sci; 2007 Mar; 45(3):153-60. PubMed ID: 17169531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atypical hydroa vacciniforme-like epstein-barr virus associated T/NK-cell lymphoproliferative disorder.
    Lee HY; Baek JO; Lee JR; Park SH; Jeon IS; Roh JY
    Am J Dermatopathol; 2012 Dec; 34(8):e119-24. PubMed ID: 23169419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders.
    Iwatsuki K; Satoh M; Yamamoto T; Oono T; Morizane S; Ohtsuka M; Xu ZG; Suzuki D; Tsuji K
    Arch Dermatol; 2006 May; 142(5):587-95. PubMed ID: 16702496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of mortality in hydroa vacciniforme and hypersensitivity to mosquito bites.
    Poligone B
    Br J Dermatol; 2015 Jan; 172(1):5-6. PubMed ID: 25581582
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic active Epstein-Barr virus infection of natural killer cells presenting as severe skin reaction to mosquito bites.
    Pacheco SE; Gottschalk SM; Gresik MV; Dishop MK; Okmaura T; McCormick TG
    J Allergy Clin Immunol; 2005 Aug; 116(2):470-2. PubMed ID: 16083813
    [No Abstract]   [Full Text] [Related]  

  • 16. Epstein-Barr virus involvement in the pathogenesis of hydroa vacciniforme: an assessment of seven adult patients with long-term follow-up.
    Verneuil L; Gouarin S; Comoz F; Agbalika F; Creveuil C; Varna M; Vabret A; Janin A; Leroy D
    Br J Dermatol; 2010 Jul; 163(1):174-82. PubMed ID: 20367637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe mosquito bite hypersensitivity, natural killer cell leukaemia, latent or chronic active Epstein-Barr virus infection and hydroa vacciniforme-like eruption.
    Tokura Y; Ishihara S; Ohshima K; Hidano A; Koide M; Seo N; Takigawa M
    Br J Dermatol; 1998 May; 138(5):905-6. PubMed ID: 9666846
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary EBV infection and hypersensitivity to mosquito bites: a case report.
    Kyriakidis I; Vasileiou E; Karastrati S; Tragiannidis A; Gompakis N; Hatzistilianou M
    Virol Sin; 2016 Dec; 31(6):517-520. PubMed ID: 27900557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child.
    Wu YH; Chen HC; Hsiao PF; Tu MI; Lin YC; Wang TY
    Int J Dermatol; 2007 Oct; 46(10):1081-6. PubMed ID: 17910721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment of chronic active EBV infection].
    Kawa K
    Uirusu; 2002 Dec; 52(2):257-60. PubMed ID: 12685317
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.